Abstract
Left ventricular hypertrophy (LVH) measured by echocardiography is a powerful independent marker of increased cardiovascular risk. The prevalence of echocardiographic LVH in patients with high cardiovascular risk appears to be high, even in patients currently considered normotensive.
Original language | English |
---|---|
Pages (from-to) | 87-93 |
Number of pages | 7 |
Journal | QJM : an International Journal of Medicine |
Volume | 97 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2004 |